Where AI meets scalable, reliable drug development.
Silico Biosciences is an AI-driven biotech organization focused on accelerating drug discovery using advanced computational models. We develop protein language models that generate and optimize antibody sequences, aiming to turn in silico approaches into life-saving therapeutic molecules. Our flagship project, 🦋 peleke-1, is a suite of targeted antibody sequence generation models.